These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8510490)

  • 1. Histological outcome of chronic hepatitis C treated with a 12-month course of lymphoblastoid alfa interferon.
    de Alava E; Camps J; Pardo-Mindán J; García-Granero M; Muñoz M; Sola J; Civeira MP; Contreras F; Vázquez JJ; Castilla A
    Liver; 1993 Apr; 13(2):73-9. PubMed ID: 8510490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time course of histological changes in patients with a sustained biochemical and virological response to interferon-alpha therapy for chronic hepatitis C virus infection.
    Tsubota A; Kumada H; Chayama K; Arase Y; Saitoh S; Koida I; Suzuki Y; Kobayashi M; Murashima N; Ikeda K
    J Hepatol; 1997 Jul; 27(1):49-55. PubMed ID: 9252073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histological outcome in patients with chronic hepatitis C given a 60-week interferon alfa-2b treatment course.
    Reichard O; Glaumann H; Norkrans G; Wejstål R; Fryden A; Schvarcz R; Weiland O
    Liver; 1994 Aug; 14(4):169-74. PubMed ID: 7526108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of interferon on the liver in chronic hepatitis C: a quantitative evaluation of histology by meta-analysis.
    Cammà C; Giunta M; Linea C; Pagliaro L
    J Hepatol; 1997 Jun; 26(6):1187-99. PubMed ID: 9210603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term histological outcome in patients with chronic hepatitis C treated repeatedly with interferon alpha-2b without sustained response.
    Reichard O; Glaumann H; Weiland O
    Scand J Infect Dis; 1994; 26(4):383-9. PubMed ID: 7984968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphoblastoid interferon alfa treatment in chronic hepatitis C.
    Iorio R; Pensati P; Porzio S; Fariello I; Guida S; Vegnente A
    Arch Dis Child; 1996 Feb; 74(2):152-6. PubMed ID: 8660080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between biochemical, virological, and histological response during interferon treatment of chronic hepatitis C.
    Shiffman ML; Hofmann CM; Thompson EB; Ferreira-Gonzalez A; Contos MJ; Koshy A; Luketic VA; Sanyal AJ; Mills AS; Garrett CT
    Hepatology; 1997 Sep; 26(3):780-5. PubMed ID: 9303513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of sustained remission of chronic hepatitis C after a 12-month course of alfa interferon.
    Camps J; García-Granero M; Riezu-Boj JI; Larrea E; de Alava E; Civeira MP; Castilla A; Prieto J
    J Hepatol; 1994 Jul; 21(1):4-11. PubMed ID: 7963420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomised trial of lymphoblastoid alpha-interferon in chronic hepatitis C. Effects on inflammation, fibrogenesis and viremia.
    Camps J; Castilla A; Ruiz J; Civeira MP; Prieto J
    J Hepatol; 1993 Mar; 17(3):390-6. PubMed ID: 8391042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant interferon-alpha and ursodeoxycholic acid versus interferon-alpha alone in the treatment of chronic hepatitis C: a randomized clinical trial with long-term follow-up.
    Angelico M; Gandin C; Pescarmona E; Rapicetta M; Del Vecchio C; Bini A; Spada E; Baroni CD; Capocaccia L
    Am J Gastroenterol; 1995 Feb; 90(2):263-9. PubMed ID: 7847298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A histopathological study of the effects of 6-month versus 12-month interferon alpha-2b therapy in chronic hepatitis C.
    Ziol M; Nhieu JT; Roudot-Thoraval F; Métreau JM; Deugnier Y; Dhumeaux D; Zafrani ES
    J Hepatol; 1996 Dec; 25(6):833-41. PubMed ID: 9007710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-alpha 2b therapy reduces liver fibrosis in chronic non-A, non-B hepatitis: a quantitative histological evaluation.
    Manabe N; Chevallier M; Chossegros P; Causse X; Guerret S; Trépo C; Grimaud JA
    Hepatology; 1993 Dec; 18(6):1344-9. PubMed ID: 8244259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of chronic hepatitis C with interferon-alpha. Clinical histological and virological implications.
    Olaso V; Córdoba J; Berenguer M; Prieto M; Lainez B; Argüello L; Valverde J; Pascual S; Gobernado M; Berenguer J
    Rev Esp Enferm Dig; 1997 Jul; 89(7):531-50. PubMed ID: 9265839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histological changes but not virus eradication reflect biochemical improvement in chronic hepatitis C patients showing a long-term response to interferon alpha therapy.
    Bruno S; Manzin A; Roncalli M; Petroni ML; Rossi S; Pedicino M; Larghi A; Crosignani A; Podda M
    Ital J Gastroenterol Hepatol; 1997 Feb; 29(1):31-7. PubMed ID: 9265576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GB virus C (GBV-C) infection in patients with chronic hepatitis C. Influence on liver disease and on hepatitis virus behaviour: effect of interferon alfa therapy.
    Pawlotsky JM; Roudot-Thoraval F; Muerhoff AS; Pellerin M; Germanidis G; Desai SM; Bastie A; Darthuy F; Rémiré J; Zafrani ES; Soussy CJ; Mushahwar IK; Dhumeaux D
    J Med Virol; 1998 Jan; 54(1):26-37. PubMed ID: 9443106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histological outcome in interferon alpha-2b treated patients with chronic posttransfusion non-A, non-B hepatitis.
    Schvarcz R; Glaumann H; Weiland O; Norkrans G; Wejstål R; Frydén A
    Liver; 1991 Feb; 11(1):30-8. PubMed ID: 1646369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphoblastoid interferon therapy in chronic hepatitis C: biochemical, virological and histological evaluation of two different doses.
    Picciotto A; Callea F; Varagona G; Bardellini E; Borzone S; De Conca V; Vallarino E; Giudici-Cipriani A; Vitali A; Grasso A
    Liver; 1995 Feb; 15(1):20-4. PubMed ID: 7776853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and histological evaluation of interferon alfa-2b in the treatment of chronic hepatitis C.
    Panella C; Francavilla A; Conte D; Tatulli I; Rubini F
    Gut; 1993; 34(2 Suppl):S127. PubMed ID: 8314478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of chronic hepatitis D with interferon alfa-2a.
    Farci P; Mandas A; Coiana A; Lai ME; Desmet V; Van Eyken P; Gibo Y; Caruso L; Scaccabarozzi S; Criscuolo D
    N Engl J Med; 1994 Jan; 330(2):88-94. PubMed ID: 8259188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment with interferon alfa-2b in patients with chronic hepatitis caused by hepatitis C virus: predictive factors for the response, relapse and early development to cirrhosis after treatment].
    Pérez Roldán F; De Diego A; Casado M; Matilla A; Bañares R; García-Durán F; Salcedo M; Cos E; Clemente G
    Rev Esp Enferm Dig; 1996 Sep; 88(9):609-15. PubMed ID: 8962775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.